This transcript presents a detailed dermatopathology case study of a spindle cell lesion located on the lower leg of a 57-year-old female. The discussion focuses on differentiating the lesion from Dermatofibrosarcoma Protuberans (DFSP).
Microscopically, the tumor is highly cellular and composed of plump, bland spindle cells that exhibit collagen trapping at the periphery and form long, intersecting fascicles. Despite the hypercellularity, significant atypia or necrosis is absent. The diagnosis established is Cellular Dermatofibroma (Cellular Fibrocysteocytoma).
The video highlights classical features of dermatofibroma (DF), including epidermal acanthosis and increased melanin pigmentation. Key pathological contrasts are drawn with DFSP—DFSP typically shows prominent fat entrapment and is cytologically bland, whereas DF can show atypia and mitosis. The utility of CD34 immunostaining is discussed as the primary diagnostic differentiator, cautioning pathologists about the common "halo" of positive staining found at the periphery of a DF, which can mimic DFSP. The speaker concludes by addressing the slightly increased risk of local recurrence associated with cellular DF, attributing it mainly to persistence after incomplete excision rather than aggressive biological behavior.
Summarizing the Transcript: Pathologic Differentiation of Cellular Dermatofibroma
0:08 Case Introduction: The case involves a 57-year-old female patient presenting with a cellular, spindle cell lesion on the lower leg.
0:24 Pathological Features at Low Power: The lesion is highly cellular, non-circumscribed (trickles out or "feathers" at the edges), and notably exhibits collagen trapping (thick, bright pink reticular dermal collagen bundles are wrapped around by the spindle cells).
1:25 Cytological Assessment: The tumor cells are described as bland and slightly plump ("fat juicy looking") spindle cells, lacking dramatic atypia or necrosis. Mitosis is expected in DF but was not immediately located.
1:54 Differential Diagnosis: The primary differential considered was Cellular Dermatofibroma (DF) versus Dermatofibrosarcoma Protuberans (DFSP). DFSP was ruled out due to the absence of prominent fat entrapment/invasion.
2:44 Diagnosis and Definition: The lesion is diagnosed as Cellular Dermatofibroma (synonym: cellular fibrocysteocytoma). Defining a DF as "cellular" is subjective but often applied when there is hypercellularity coupled with long, streamy, intersecting fascicles (almost a herringbone pattern) of spindle cells.
DF: Can exhibit atypia, monster cells, and mitosis (these features paradoxically favor DF over DFSP). Typically shows collagen trapping.
DFSP: Usually cytologically bland (translocation sarcoma), characterized by very thin, stretched-out cells and prominent fat entrapment.
4:57 Associated Epidermal Changes (Key DF Feature): The overlying epidermis often shows acanthosis (elongated Rete ridges) and increased basal layer melanin pigment (explaining the common brown color of DF clinically). It can also show "tabling" (flattening of the Rete ridges) or follicular induction (hair follicle overgrowth, which can be mistaken for Basal Cell Carcinoma).
6:56 Risk of Local Recurrence: Cellular DF is associated with a higher risk of local recurrence. This risk is primarily attributed to persistence (incomplete removal via superficial biopsy, especially since these lesions are often large and deep) rather than aggressive growth. Metastasis is exceedingly rare (reported mainly in cellular or aneurysmal types).
8:47 Immunostain for Differentiation (Takeaway): The single most useful stain to distinguish DF from DFSP is CD34.
DFSP is typically solid, diffuse, and strongly positive for CD34.
DF is usually negative in the center. Crucial Pitfall: DF often displays a "Halo" of strong CD34 staining around the periphery, caused by trapped normal dermal dendritic cells, which must not be mistaken for DFSP positivity.
10:30 Other Stains: Factor 13A is mentioned but dismissed as unhelpful for resolving spindle cell tumors.
10:51 Clinical Implications: For partial biopsies, the pathologist should comment on the potential for deeper growth and local recurrence to guide the clinician toward conservative excision or diligent follow-up.